Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease
Authors
Keywords
-
Journal
Neural Regeneration Research
Volume 18, Issue 1, Pages 226
Publisher
Medknow
Online
2022-05-06
DOI
10.4103/1673-5374.344841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (D-Ser2) oxyntomodulin recovers hippocampal synaptic structure and theta rhythm in Alzheimer’s disease transgenic mice
- (2022) Jin-Shun Qi et al. Neural Regeneration Research
- Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery
- (2021) Duygu Ege Materials
- Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
- (2021) Surabhi Shukla et al. Neural Regeneration Research
- Brain microRNAs dysregulation: implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer’s disease and related tauopathies
- (2020) Maryam Bazrgar et al. PHARMACOLOGICAL RESEARCH
- Ligand conjugated targeted nanotherapeutics for treatment of neurological disorders
- (2020) Saurabh Mittal et al. CURRENT PHARMACEUTICAL DESIGN
- Biological properties and clinical applications of berberine
- (2020) Danyang Song et al. Frontiers of Medicine
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Drug repositioning and repurposing for Alzheimer disease
- (2020) Clive Ballard et al. Nature Reviews Neurology
- Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
- (2020) Alba Calvo et al. Pharmaceutics
- Involvement of endoplasmic reticulum stress in amyloid β (1-42)-induced Alzheimer’s like neuropathological process in rat brain
- (2020) Poonam Goswami et al. BRAIN RESEARCH BULLETIN
- Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer’s Disease
- (2020) Jeffrey Cummings JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Neuropharmacokinetic Evaluation of Lactoferrin-Treated Indinavir-Loaded Nanoemulsions: Remarkable Brain Delivery Enhancement
- (2019) Zahra Karami et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
- (2019) Ning-Ning Yuan et al. BMC Complementary and Alternative Medicine
- Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice
- (2019) Dafeng Bai et al. Journal of Physiological Sciences
- Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer’s Disease in Mice
- (2019) Avinash Gothwal et al. BIOCONJUGATE CHEMISTRY
- Therapeutic potential and recent delivery systems of berberine: A wonder molecule
- (2019) Marina Raju et al. Journal of Functional Foods
- Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
- (2019) Divya Gopalan et al. JOURNAL OF CONTROLLED RELEASE
- Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link
- (2018) Ying Zhang et al. BEHAVIOURAL BRAIN RESEARCH
- Nano strategies for berberine delivery, a natural alkaloid of Berberis
- (2018) Elaheh Mirhadi et al. BIOMEDICINE & PHARMACOTHERAPY
- Estrogen-related receptor alpha is involved in Alzheimer's disease-like pathology
- (2018) Ying Tang et al. EXPERIMENTAL NEUROLOGY
- Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
- (2018) Xiuju Yan et al. International Journal of Nanomedicine
- Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
- (2018) Qingqing Meng et al. International Journal of Nanomedicine
- Design of lactoferrin modified lipid nano-carriers for efficient brain-targeted delivery of nimodipine
- (2018) Chaoyue Zhao et al. Materials Science & Engineering C-Materials for Biological Applications
- PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure
- (2018) Lingxuan Mo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Fluorescence Imaging of Alzheimer's Disease with a Flat Ensemble Formed between a Quinoline-Malononitrile AIEgen and Thin-Layer Molybdenum Disulfide
- (2018) Wei-Tao Dou et al. CHEMBIOCHEM
- Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms
- (2018) Sepideh Sadraie et al. METABOLIC BRAIN DISEASE
- Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma
- (2017) Shuang Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease
- (2017) Min Huang et al. EXPERIMENTAL GERONTOLOGY
- Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease
- (2017) Mukta Agrawal et al. JOURNAL OF CONTROLLED RELEASE
- Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction
- (2017) Iris E. Allijn et al. JOURNAL OF CONTROLLED RELEASE
- Preparation, pharmacokinetics and tumour-suppressive activity of berberine liposomes
- (2017) Xinghui Wang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer’s disease
- (2017) J Chu et al. MOLECULAR PSYCHIATRY
- Berberine attenuates cognitive impairment and ameliorates tau hyperphosphorylation by limiting the self-perpetuating pathogenic cycle between NF-κB signaling, oxidative stress and neuroinflammation
- (2017) Wenbo He et al. Pharmacological Reports
- Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats
- (2017) Qingjie Chen et al. Frontiers in Pharmacology
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Old and new acetylcholinesterase inhibitors for Alzheimer’s disease
- (2016) Daniela Galimberti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Silibinin rescues learning and memory deficits by attenuating microglia activation and preventing neuroinflammatory reactions in SAMP8 mice
- (2016) Ge Jin et al. NEUROSCIENCE LETTERS
- Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer’s-like dementia: Involvement of acetylcholinesterase and cell death
- (2016) Juliana Sorraila de Oliveira et al. NEUROTOXICOLOGY
- New Developments in Liposomal Drug Delivery
- (2015) Bhushan S. Pattni et al. CHEMICAL REVIEWS
- In vivo rapid fluorescence imaging of Alzheimer’s disease through accurate target bio-marking of zinc gluconate
- (2015) Lanmei Lai et al. Science Bulletin
- Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1-42
- (2014) Xue-Fei Ji et al. Evidence-based Complementary and Alternative Medicine
- In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery
- (2013) Feng-Yun Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method
- (2013) Xiang Luo et al. Asian Journal of Pharmaceutical Sciences
- Optimizing manufacture of liposomal berberine with evaluation of its antihepatoma effects in a murine xenograft model
- (2012) Yung-Chang Lin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
- (2012) Siva Sundara Kumar Durairajan et al. NEUROBIOLOGY OF AGING
- Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
- (2012) Yale Duan et al. Translational Neurodegeneration
- Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1
- (2011) Ben A. Croker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Sensitive Protein Concentration Assay over a Wide Range via Surface-Enhanced Raman Scattering of Coomassie Brilliant Blue
- (2010) Xiao Xia Han et al. ANALYTICAL CHEMISTRY
- Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation
- (2009) Chiraz Jaafar-Maalej et al. JOURNAL OF LIPOSOME RESEARCH
- Conformation-activity studies on the interaction of berberine with acetylcholinesterase: Physical chemistry approach
- (2009) Jin Xiang et al. Progress in Natural Science-Materials International
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started